COVID-19 has killed more than 1.1 million Americans since January 2020, but weekly deaths have fallen more than 98% from their 2021 peak of nearly 26,000 to just 484 at the highest point recorded in 2026. The disease no longer ranks among the nation’s top 10 leading causes of death.
Death from COVID – Introduction
COVID Deaths in the United States has undergone a dramatic transformation since the early pandemic years, shifting from a leading cause of mortality that claimed more than 400,000 lives in a single year to a comparatively rare outcome tracked mainly through weekly surveillance data. The Centers for Disease Control and Prevention and the National Center for Health Statistics continue to record and code COVID-19 deaths using the same rigorous methodology established in 2020, allowing for a clear year-over-year comparison that shows just how far the disease’s lethality has fallen even as it continues circulating widely across the population.
That said, COVID-19 has not disappeared, and 2026 has brought a renewed summer uptick in activity that has kept public health officials watching closely. With infections growing or likely growing across dozens of states heading into the fall and a new dominant variant driving the bulk of current cases, understanding exactly how many people are still dying from COVID-19, who faces the highest risk, and how this year compares to the disease’s deadliest years remains an important, ongoing part of the national health picture.
Six years into official tracking, the data now tells a much fuller story than was possible during the pandemic’s early, chaotic months. Year-over-year comparisons, demographic breakdowns, and weekly surveillance trends all draw on a mature, well-established reporting infrastructure built by the CDC and NCHS, giving public health researchers and the general public alike a far clearer picture of where COVID-19 mortality stands today than was available even two or three years ago.
Interesting Facts about COVID Death
| Fact | Figure |
|---|---|
| Cumulative US COVID-19 Deaths Since January 2020 | More than 1.1 million |
| Deadliest Year on Record | 2021, with 415,399 deaths |
| Lowest Annual Death Total (2025, Provisional) | ~20,190 deaths |
| Weekly Death Peak, 2021 | Nearly 26,000 per week |
| Weekly Death Peak, 2026 | 484 per week |
| Decline From 2021 Weekly Peak to 2026 Weekly Peak | More than 98% |
| Current Ranking Among Leading Causes of Death | Outside the top 10 |
| States With Growing COVID-19 Activity (September 2026) | 47 of 50 |
Source: CDC National Center for Health Statistics, CDC Respiratory Virus Surveillance
These interesting facts about death from COVID capture the scale of the disease’s transformation over six years of tracking. The collapse from a 2021 weekly peak of nearly 26,000 deaths to a 2026 weekly peak of just 484 represents a decline of more than 98%, a shift that reflects widespread immunity from both vaccination and prior infection, improved treatments, and a virus that has evolved toward greater transmissibility rather than greater severity.
Even so, the disease remains active enough that 47 of 50 states reported growing or likely growing infection activity heading into September 2026, a reminder that lower death rates have not meant the complete disappearance of COVID-19 from the national health landscape.
The gap between rising infection activity and stubbornly low death counts illustrates just how much the relationship between COVID-19 transmission and COVID-19 mortality has changed since the pandemic’s early years. In 2020 and 2021, rising case counts reliably preceded rising death counts within a matter of weeks. By 2026, that link has weakened considerably, with widespread population immunity and improved treatment options meaning that even meaningful upticks in transmission now translate into comparatively modest increases in severe outcomes and deaths.
COVID-19 Deaths by Year in the US (2020-2026)
| Year | COVID-19 Deaths (Underlying Cause) | Death Rate per 100,000 |
|---|---|---|
| 2020 | 350,831 | 105.8 |
| 2021 | 415,399 | 125.1 |
| 2022 | 186,702 | 56.0 |
| 2023 | 76,446 | 22.8 |
| 2024 | ~47,000 | 14.0 |
| 2025 | ~20,190 (provisional) | 5.9 |
| 2026 | Data incomplete (year in progress) | Not yet finalized |
Source: CDC National Center for Health Statistics, final and provisional mortality data
The year-by-year COVID-19 death toll traces a clear downward arc since the pandemic’s deadliest stretch. 2021 stands as the single deadliest year, with 415,399 deaths and a rate of 125.1 per 100,000 people, even surpassing 2020’s already devastating 350,831 deaths. That 2021 peak reflected the combination of the more severe Delta variant and a vaccination campaign still in its early stages of reaching full population coverage.
Each subsequent year has recorded a substantial decline, with 2025’s provisional total of roughly 20,190 deaths representing a drop of approximately 95% from the 2021 peak. COVID-19 Deaths by State in US tracking how this decline has played out geographically show that while every state has seen dramatic improvement, the pace and timing of that decline has varied considerably depending on regional vaccination rates, healthcare access, and demographic factors like the share of elderly residents in each state’s population.
The transition from 2022 through 2025 shows a remarkably consistent year-over-year decline pattern, roughly halving or better with each passing year, a trajectory that public health researchers describe as consistent with a pathogen settling into endemic circulation after an initial pandemic period. Full-year 2026 figures remain incomplete as official reporting continues, though early indicators through the first three quarters of the year suggest the broader downward trend has largely held steady, even accounting for the modest summer uptick in overall infection activity.
Current COVID-19 Death Trends in 2026
| Metric | Figure (2026) |
|---|---|
| Weekly Death Peak Recorded in 2026 | 484 deaths |
| States With Growing/Likely Growing Activity (Sept 2, 2026) | 47 of 50 |
| States/Territories With Active Outbreaks (Sept 7, 2026) | At least 33 |
| National Wastewater COVID Activity Level (Early Sept 2026) | “Very low” |
| Dominant Variant | “Nimbus” (NB.1.8.1) |
| Nimbus Share of Sequenced Cases (Late June 2026) | 43% |
Source: CDC COVID Data Tracker, Pandemic Mitigation Collaborative
COVID-19 activity in 2026 has followed a now-familiar seasonal pattern, with a modest summer surge building through July and August before health officials began watching closely for further growth heading into fall. Despite 47 of 50 states showing growing or likely growing infection activity by early September, CDC’s own wastewater surveillance data classified overall national COVID activity as “very low” during the same period, illustrating how much lower the baseline level of severe disease has become even during periods of rising transmission.
The “Nimbus” variant, formally designated NB.1.8.1, emerged as the dominant strain nationally, accounting for 43% of sequenced cases by late June 2026. Infectious disease experts monitoring the summer uptick described the national trend as a gradual tick upward rather than a substantial increase, a notably more measured characterization than the alarm that accompanied earlier pandemic-era surges, reflecting both the medical community’s and the public’s adjustment to COVID-19 as an ongoing but far less severe seasonal respiratory illness.
Regional variation has also played a role in shaping the 2026 summer trend, with the CDC’s own seasonal outlook specifically flagging the South and West as regions most likely to see growth heading into the warmer months. That geographic pattern has held broadly consistent with prior summer seasons since the pandemic’s acute phase ended, suggesting a recurring seasonal rhythm has emerged around COVID-19 transmission that public health officials now factor into their annual surveillance planning and vaccine timing recommendations.
COVID-19 Death Rate per 100,000 in the US 2026
| Year | Estimated US Population | COVID-19 Death Rate (per 100,000) |
|---|---|---|
| 2020 | 331.5 million | 105.8 |
| 2021 | 332.0 million | 125.1 |
| 2022 | 333.3 million | 56.0 |
| 2023 | 334.9 million | 22.8 |
| 2024 | 336.8 million | 14.0 |
| 2025 | 341.0 million | 5.9 |
Source: CDC National Center for Health Statistics, US Census Bureau population estimates
Tracking the COVID-19 death rate per 100,000 residents rather than raw death counts helps account for the country’s growing population over the same period, and the trend line shows an even steeper decline than raw numbers alone suggest. The rate fell from a peak of 125.1 per 100,000 in 2021 to just 5.9 per 100,000 in 2025, a drop of roughly 95% across four years, even as the total US population grew by nearly 9 million people over the same span.
Death Statistics in U.S covering overall national mortality trends provide useful context for how unusual this kind of rapid rate decline actually is, since most causes of death show far more gradual year-over-year movement. The speed of COVID-19’s decline reflects the unique circumstances of a novel pathogen encountering a population that developed substantial layered immunity within just a few years through the combination of vaccination campaigns and repeated natural infection exposure.
That rapid decline also stands in contrast to how slowly most chronic disease death rates typically shift from year to year, since conditions like heart disease and cancer tend to move only marginally even over a full decade of public health intervention. COVID-19’s comparatively swift transition from a top-three killer to a far less prominent cause of death offers researchers a useful, if tragic, case study in how quickly population-level immunity dynamics can reshape a disease’s overall mortality burden once sufficient combined vaccine and natural immunity coverage has been reached.
COVID-19 Ranking Among Leading Causes of Death in 2026
| Metric | Detail |
|---|---|
| COVID-19 Ranking, 2020 | 3rd leading cause of death |
| COVID-19 Ranking, 2021 | 3rd leading cause of death |
| COVID-19 Ranking, 2026 | Outside the top 10 |
| Share of Coded COVID Deaths With COVID as Underlying Cause | 86% |
| Highest-Risk Age Group | Adults aged 85 and older |
Source: CDC National Center for Health Statistics
COVID-19’s fall from 3rd leading cause of death in both 2020 and 2021 to a ranking outside the top 10 by 2026 marks one of the most dramatic repositionings of any major cause of death in recent American public health history. Leading Causes of Death Statistics in US covering the full current ranking of what kills Americans each year show heart disease and cancer continuing to dominate the top of that list, with COVID-19 now competing in a much lower tier alongside other respiratory illnesses rather than standing out as a singular national health emergency.
Age remains the single strongest predictor of COVID-19 mortality risk even as overall numbers have fallen. Adults aged 85 and older continue to face the highest death rates from the disease by a wide margin, a pattern that has held consistent since the earliest months of the pandemic and continues to shape how public health officials target booster vaccination outreach and clinical treatment guidance. NCHS coding data also shows that 86% of recently coded COVID-19 deaths identify the virus as the underlying cause of death rather than merely a contributing factor, indicating that the disease continues to be the primary driver in the large majority of cases where it appears on a death certificate.
High-Risk Groups and Long COVID in 2026
| Metric | Figure |
|---|---|
| US Adults Currently Affected by Long COVID | Estimated 17 million |
| Highest-Risk Age Group for Death | 85 and older |
| Most Affected Population Group, 2020 Death Rate | American Indian/Alaska Native persons |
| Weekly ED Visits Due to COVID-19 (Mid-2026) | ~0.17% of all emergency visits |
Source: CDC, NCHS demographic mortality analysis
Beyond acute deaths, long COVID continues to affect a substantial share of the American population, with an estimated 17 million US adults currently experiencing lingering symptoms following a COVID-19 infection. While long COVID itself is rarely coded as a direct cause of death, its lasting impact on quality of life and healthcare utilization represents a significant, ongoing consequence of the pandemic that persists even as acute death rates have fallen dramatically.
Demographic disparities that emerged early in the pandemic have also left a lasting mark on the cumulative death toll. American Indian and Alaska Native populations recorded the highest COVID-19 death rate of any racial or ethnic group during 2020, a disparity researchers attributed to a combination of healthcare access barriers, higher rates of underlying health conditions, and multigenerational household living arrangements that made containing early spread more difficult in many tribal communities. Emergency department visits tied to COVID-19 have settled at a comparatively low, stable share of overall ED activity through much of 2026, hovering around 0.17% of all visits during recent reporting weeks.
That early demographic gap has narrowed considerably in the years since, as vaccination campaigns specifically targeted historically underserved communities and healthcare access gaps gradually closed in many regions. Even so, researchers tracking cumulative mortality data note that the initial disparities recorded in 2020 continue to shape overall lifetime death rate comparisons across racial and ethnic groups, since those early losses occurred before vaccines or improved treatment protocols were widely available to offset the disproportionate impact.
Vaccine Uptake and COVID-19 Deaths in 2026
| Metric | Figure |
|---|---|
| Adult Vaccine Uptake, 2025-26 Season (as of Feb 22, 2026) | 17.5% of adults 18+ |
| Weekly Hospital Admissions (Week Ending July 18, 2026) | ~1,200 confirmed admissions |
| Public Health Emergency Status | Ended May 2023 |
Source: CDC COVID Data Tracker
Vaccine uptake for the 2025-26 season reached just 17.5% of adults 18 and older as of late February 2026, a substantially lower participation rate than earlier in the pandemic when initial vaccine rollout drove much higher uptake numbers within comparable timeframes. That lower uptake rate has occurred even as the vaccines themselves have continued showing effectiveness against severe outcomes, reflecting a broader national shift in risk perception now that the federal public health emergency officially ended back in May 2023.
Hospital admission data offers another lens on the disease’s current, more moderate impact: roughly 1,200 confirmed COVID-19 hospital admissions were recorded nationally during the week ending July 18, 2026, a figure that, while still meaningful, sits far below the tens of thousands of weekly admissions recorded during the pandemic’s worst surges in 2020 and 2021. Public health officials continue to recommend vaccination for high-risk groups, particularly adults 65 and older and those with underlying health conditions, even as the disease has settled into a pattern more consistent with a seasonal respiratory illness than an ongoing public health emergency.
Death from COVID – FAQ
How many people have died from COVID-19 in the US since 2020?
More than 1.1 million Americans have died from COVID-19 since January 2020, based on cumulative CDC and NCHS mortality data.
What was the deadliest year for COVID-19 deaths in the US?
2021 was the deadliest year on record, with 415,399 deaths, surpassing even 2020’s total of 350,831.
How many people are currently dying from COVID-19 each week?
Weekly COVID-19 deaths peaked at 484 in 2026, down more than 98% from the 2021 weekly peak of nearly 26,000.
Where does COVID-19 rank among leading causes of death in 2026?
COVID-19 has fallen outside the top 10 leading causes of death, down from ranking 3rd in both 2020 and 2021.
Which age group faces the highest risk of dying from COVID-19?
Adults aged 85 and older continue to face the highest COVID-19 death rates of any age group.
What is the dominant COVID-19 variant in the US in 2026?
The “Nimbus” variant (NB.1.8.1) became the dominant strain, accounting for 43% of sequenced cases as of late June 2026.
How many Americans are currently affected by long COVID?
An estimated 17 million US adults are currently affected by long COVID symptoms.
What is the current adult COVID-19 vaccine uptake rate?
Only 17.5% of adults 18 and older received a COVID-19 vaccine during the 2025-26 season, as of late February 2026.
Is COVID-19 activity increasing or decreasing in 2026?
Activity has been rising modestly, with 47 of 50 states reporting growing or likely growing infection activity as of early September 2026, though overall wastewater levels remained classified as “very low.”
When did the COVID-19 public health emergency officially end?
The federal COVID-19 public health emergency ended in May 2023, though CDC surveillance and death tracking have continued without interruption since then.
What percentage of coded COVID-19 deaths list COVID as the underlying cause?
86% of recently coded COVID-19 deaths identify the virus as the underlying cause of death rather than merely a contributing factor.
Which regions were flagged for the biggest summer 2026 COVID-19 growth?
The CDC’s 2026 Summer Outlook specifically flagged the South and West regions as most likely to see growing COVID-19 activity during the warmer months.
Disclaimer: The data research report we present here is based on information found from various sources. We are not liable for any financial loss, errors, or damages of any kind that may result from the use of the information herein. We acknowledge that though we try to report accurately, we cannot verify the absolute facts of everything that has been represented.
